What is Contact Urticaria
Contact urticaria is an immediate hypersensitivity reaction that develops within minutes to an hour after skin or mucosal contact with specific proteins or chemicals, manifesting as localized wheals, itching, burning, and swelling at the contact site 1.
Clinical Definition and Classification
Contact urticaria presents as a wheal-and-flare reaction following direct external contact with a causative substance 2. The condition is classified into two main types 3, 1:
- Non-immunologic contact urticaria (NI-CoU): Triggered by low molecular weight chemicals through direct mast cell activation without IgE involvement
- Immunologic contact urticaria (I-CoU): IgE-mediated hypersensitivity to both high and low molecular weight proteins and chemicals, which can progress to anaphylaxis
The British Association of Dermatologists guidelines formally recognize contact urticaria as a distinct clinical pattern within the urticaria classification system, specifically noting it occurs through "contact with allergens or chemicals" 3.
Latex Condom Allergy: The Specific Clinical Scenario
In a woman developing rapid vulvar itching, burning, and swelling after latex condom use, this represents immunologic contact urticaria to latex proteins 4, 5. This is a well-documented phenomenon:
- 24% of patients with latex glove contact urticaria experience local genital symptoms during condom use 4
- Condoms contain extractable latex proteins similar to those in rubber gloves, confirmed by high-pressure liquid chromatography 4
- The reaction can range from localized vulvar symptoms to systemic anaphylaxis 5
Diagnostic Approach
For suspected latex contact urticaria from condoms, perform skin prick testing with latex extracts or pieces of the actual condom 4, 5. The diagnostic workup should include:
- Detailed exposure history: Timing of symptom onset (minutes to 1 hour), specific products used, pattern of reactions
- Skin prick testing: Gold standard for I-CoU diagnosis; can test actual condom material 4
- Serum-specific IgE (RAST): Confirmatory testing for latex allergy 5
- Short-term occlusive testing: Alternative immediate-testing protocol when prick testing unavailable 6
A critical pitfall: Standard patch testing will miss contact urticaria entirely, as it only detects delayed-type hypersensitivity (Type IV), not immediate IgE-mediated reactions (Type I) 6.
Management Strategy
The primary management is strict avoidance of latex condoms; substitute with polyurethane or polyisoprene non-latex alternatives 1, 4.
Pharmacological Management
For I-CoU when complete avoidance is not possible 1:
- First-line: Second-generation H1-antihistamines (non-sedating)
- Severe cases: Omalizumab (anti-IgE therapy)
- Anaphylaxis risk: Prescribe epinephrine auto-injector and medical alert bracelet 1
Specific Considerations for Genital Contact Urticaria
- Test intimate hygiene products and topical medications used in the genital area, as these can be additional sensitizers 7
- Consider cross-reactivity with other latex-containing products (gloves, balloons, medical devices) 4
- Evaluate for concurrent atopic conditions (allergic rhinitis, asthma, food allergies), which commonly coexist with I-CoU 1
Important Clinical Caveats
The diagnosis of latex contact urticaria is difficult to make on history alone and requires objective testing 5. Not all condom brands are equally allergenic—some contain significantly more extractable latex protein than others, with allergenicity ranging from 0% to 67% positivity on prick testing 4. However, given the potential for anaphylaxis, complete latex avoidance is warranted once the diagnosis is established.
The term "contact urticaria" should be restricted to actual skin reactions; systemic symptoms represent progression to contact urticaria syndrome or anaphylaxis 2. Patients with genital contact urticaria from latex are at risk for systemic reactions and should be counseled about anaphylaxis risk 1, 5.